Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy
Public ClinicalTrials.gov record NCT00109603. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Pilot Study to Determine the Impact on Dyslipidemia of the Addition of Tenofovir to Stable Background Antiretroviral Therapy in HIV-Infected Subjects
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the effect of the anti-HIV drug tenofovir disoproxil fumarate (TDF) on lipid levels in HIV infected adults on stable anti-HIV drug therapy. Study hypothesis: The addition of TDF to stable background antiretroviral therapy in HIV infected individuals with dyslipidemia will result in a reduction of non-HDL after 12 weeks of treatment.
Study identification
- NCT ID
- NCT00109603
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 17 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2005
- Primary completion
- Jun 30, 2007
- Completion
- Oct 31, 2007
- Last update posted
- Oct 29, 2012
2005 – 2007
United States locations
- U.S. sites
- 19
- U.S. states
- 11
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Southern California | Los Angeles | California | 90033-1079 | — |
| University of California, San Diego Antiviral Research Center | San Diego | California | 92103 | — |
| University of Colorado Health Sciences Center, Denver | Denver | Colorado | 80262-3706 | — |
| University of Miami | Miami | Florida | 33136-1013 | — |
| Indiana University Hospital | Indianapolis | Indiana | 46202-5250 | — |
| Methodist Hospital of Indiana | Indianapolis | Indiana | 46202-5250 | — |
| Wishard Hospital | Indianapolis | Indiana | 46202 | — |
| University of Maryland, Institute of Human Virology | Baltimore | Maryland | 21201 | — |
| Johns Hopkins University | Baltimore | Maryland | 21287-8106 | — |
| Washington University (St. Louis) | St Louis | Missouri | 63108-2138 | — |
| Beth Israel Medical Center | New York | New York | 10003 | — |
| NYU/Bellevue | New York | New York | 10016-6481 | — |
| Duke University Medical Center | Durham | North Carolina | — | — |
| University of Cincinnati | Cincinnati | Ohio | 45267-0405 | — |
| Case Western Reserve University | Cleveland | Ohio | 44106-5083 | — |
| MetroHealth Medical Center | Cleveland | Ohio | 44109-1998 | — |
| University of Pennsylvania, Philadelphia | Philadelphia | Pennsylvania | 19104 | — |
| University of Pittsburgh | Pittsburgh | Pennsylvania | 15213-2582 | — |
| University of Texas, Galveston | Galveston | Texas | 77555-0435 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00109603, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 29, 2012 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00109603 live on ClinicalTrials.gov.